These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 13969924)

  • 1. A comparison of the renal hemodynamic effects of protamine sulfate and hexadimethrine bromide as used for heparin neutralization.
    BEALL AC
    Cardiovasc Res Cent Bull; 1963; 1():76-8. PubMed ID: 13969924
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of polybrene and protamine for heparin neutralization in open heart surgery.
    LILLEHEI CW; STERNS LP; LONG DM; LEPLEY D
    Ann Surg; 1960 Jan; 151(1):11-6. PubMed ID: 14416954
    [No Abstract]   [Full Text] [Related]  

  • 3. [NEUTRALIZATION OF EXOGENOUS HEPARIN BY PROTAMINE OR POLYBRENE IN SUBEQUIVALENT QUANTITIES AFTER ARTIFICIAL PERFUSION].
    PAUSESCU E; MARINESCU A
    Z Gesamte Inn Med; 1964 Jul; 19():SUPPL:38-43. PubMed ID: 14231857
    [No Abstract]   [Full Text] [Related]  

  • 4. Relative antiheparin potency of polybrene and protamine in patients undergoing extracorporeal circulation.
    KEATS AS; COOLEY DA; TELFORD J
    J Thorac Cardiovasc Surg; 1959 Sep; 38():362-8. PubMed ID: 14405074
    [No Abstract]   [Full Text] [Related]  

  • 5. [Exact determination of the actual blood heparin content at the moment when it is neutralized by polybrene or protamine sulfate].
    RABY C; SERVELLE M
    Hemostase; 1962 Dec; 2():325-8. PubMed ID: 13972909
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of the effects "in vitro" of polybrene and protamine on normal and heparinized blood].
    RABY C; FERNAND-LAURENT J; BERTRAND H
    Hemostase; 1962 Dec; 2():315-24. PubMed ID: 13972908
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical use of polybrene as an antiheparin agent in open heart surgery.
    BLUMBERG JB; WINTERSCHEID LC; DILLARD DH; VETTO RR; MERENDINO KA
    J Thorac Cardiovasc Surg; 1960 Mar; 39():330-6. PubMed ID: 13801711
    [No Abstract]   [Full Text] [Related]  

  • 8. [NEUTRALIZATION OF EXOGENOUS HEPARIN BY SUBEQUIVALENT DOSES OF PROTAMINE OR POLYBRENE AFTER AFTIFICIAL PERFUSIONS].
    PAUSESCO E; IONESCO M; MARINESCO A
    Hemostase; 1963; 3():359-71. PubMed ID: 14151023
    [No Abstract]   [Full Text] [Related]  

  • 9. HEPARIN METABOLISM AS RELATED TO TIME AND TEMPERATURE.
    THOMSON NB; EHRLICH F
    J Thorac Cardiovasc Surg; 1964 Jul; 48():19-28. PubMed ID: 14155511
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of the use of a new drug antagonist toward heparin (polybrene) in open heart surgery].
    TUCCI G; TOMAI F; NOVELLI GP
    Ann Ital Chir; 1961 Mar; 38():272-83. PubMed ID: 13778521
    [No Abstract]   [Full Text] [Related]  

  • 11. Hexadimethrine and protamine as antiheparin agents. An experimental comparison after totalbody perfusion in dogs.
    GOLDMAN R; HOHF RP
    Arch Surg; 1962 Sep; 85():497-502. PubMed ID: 13899835
    [No Abstract]   [Full Text] [Related]  

  • 12. Difference in the heparin-neutralizing effect of protamine and polybrene as tested by thrombotest.
    NORDOY A
    Scand J Clin Lab Invest; 1963; 15():205-10. PubMed ID: 13938906
    [No Abstract]   [Full Text] [Related]  

  • 13. The anti-heparin, anticoagulant and hypotensive properties of hexadimethrine and protamine.
    EGERTON WS; ROBINSON CL
    Lancet; 1961 Sep; 2(7203):635-7. PubMed ID: 13725907
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of effects of protamine and polybrene, with special emphasis on the factor VIII (antihemophilic globulin) deficiency induced.
    PERKINS HA; HARKINS G; GERBODE F; ROLFS MR; ACRA DJ
    J Clin Invest; 1961 Aug; 40(8 Pt 1-2):1421-30. PubMed ID: 13734399
    [No Abstract]   [Full Text] [Related]  

  • 15. RENAL TOXICITY OF POLYBRENE, (HEXADIMETHRINE BROMIDE).
    RANSDELL HT; HALLER JA; STOWENS D; BARTON PB
    J Surg Res; 1965 May; 5():195-9. PubMed ID: 14281435
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of polybrene in extracorporeal circulation].
    TAGUCHI K; KURIHARA Y; FUJIMURA K; HIRANO K
    Kyobu Geka; 1962 May; 15():307-12. PubMed ID: 13918950
    [No Abstract]   [Full Text] [Related]  

  • 17. [Discussion of the report of Marx and Borst. I. The heparinization of patients and the neutralization of heparin with protamine sulfate].
    LOELIGER EA
    Thoraxchirurgie; 1961 Jun; 9():84-90. PubMed ID: 13763096
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative study of heparin neutralization and the danger of blood clotting abnormalities with protamine and polybrene.
    ANDERSEN MN; MENDELOW M; ALFANO GA
    J Thorac Cardiovasc Surg; 1960 May; 39():613-8. PubMed ID: 13793330
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experimental study of polybrene for heparin neutralization].
    SHIMIZU H; YOSHITA S; TATAMURA S; KAWAAI S; OMOMOTO H; TSUDA H; MORIMOTO S; ONO I
    Rinsho Geka; 1962 Feb; 17():97-104. PubMed ID: 13911960
    [No Abstract]   [Full Text] [Related]  

  • 20. EVALUATION OF PROTAMINE AND HEXADIMETHRINE BROMIDE AS ANTIHEPARIN AGENTS IN EXTRACORPOREAL CIRCULATION.
    GUPTA S; BANERJEE C; BASU AK
    J Indian Med Assoc; 1963 Sep; 41():231-6. PubMed ID: 14063345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.